Anne‐Claire Doffin

465 total citations
6 papers, 239 citations indexed

About

Anne‐Claire Doffin is a scholar working on Immunology, Oncology and Cancer Research. According to data from OpenAlex, Anne‐Claire Doffin has authored 6 papers receiving a total of 239 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 1 paper in Oncology and 1 paper in Cancer Research. Recurrent topics in Anne‐Claire Doffin's work include Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (4 papers) and T-cell and B-cell Immunology (3 papers). Anne‐Claire Doffin is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Immune Response and Inflammation (4 papers) and T-cell and B-cell Immunology (3 papers). Anne‐Claire Doffin collaborates with scholars based in France, Germany and United States. Anne‐Claire Doffin's co-authors include Christophe Caux, Ivan Perrot, Jenny Valladeau‐Guilemond, Uzma Hasan, Jaromir Vlach, Massimo Tommasino, Christine Ménétrier‐Caux, Giorgio Trinchieri, Margaux Hubert and Céline Rodriguez and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and International Journal of Cancer.

In The Last Decade

Anne‐Claire Doffin

6 papers receiving 234 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne‐Claire Doffin France 5 211 104 53 23 15 6 239
Georgios Fotakis Austria 7 153 0.7× 74 0.7× 126 2.4× 17 0.7× 12 0.8× 11 225
Sofía Hidalgo Chile 3 266 1.3× 106 1.0× 54 1.0× 10 0.4× 11 0.7× 3 296
Daniel Noerenberg Germany 5 150 0.7× 65 0.6× 80 1.5× 24 1.0× 9 0.6× 6 213
Leon Yim United States 3 259 1.2× 151 1.5× 76 1.4× 21 0.9× 17 1.1× 5 319
Ananta V. Yanamandra United States 5 104 0.5× 93 0.9× 35 0.7× 14 0.6× 21 1.4× 8 157
Christine M. Minnar United States 6 119 0.6× 96 0.9× 49 0.9× 12 0.5× 17 1.1× 14 195
Natalie J. Neubert Switzerland 5 151 0.7× 114 1.1× 56 1.1× 13 0.6× 15 1.0× 6 224
Aldo Spanjaard Netherlands 5 231 1.1× 190 1.8× 75 1.4× 10 0.4× 21 1.4× 6 300
Dillon Corvino Germany 9 86 0.4× 77 0.7× 53 1.0× 12 0.5× 15 1.0× 14 175
Tomokazu Ohta Japan 5 267 1.3× 77 0.7× 49 0.9× 8 0.3× 15 1.0× 7 313

Countries citing papers authored by Anne‐Claire Doffin

Since Specialization
Citations

This map shows the geographic impact of Anne‐Claire Doffin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Claire Doffin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Claire Doffin more than expected).

Fields of papers citing papers by Anne‐Claire Doffin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Claire Doffin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Claire Doffin. The network helps show where Anne‐Claire Doffin may publish in the future.

Co-authorship network of co-authors of Anne‐Claire Doffin

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Claire Doffin. A scholar is included among the top collaborators of Anne‐Claire Doffin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Claire Doffin. Anne‐Claire Doffin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Rodriguez, Céline, Maude Ardin, Anne‐Claire Doffin, et al.. (2025). Type III interferon primes pDCs for TLR7 activation and antagonizes immune suppression mediated by TGF-β and PGE2. Nature Communications. 16(1). 3045–3045. 5 indexed citations
2.
Bayerl, Felix, David Alejandro Bejarano, Anne‐Claire Doffin, et al.. (2023). Guidelines for visualization and analysis of DC in tissues using multiparameter fluorescence microscopy imaging methods. European Journal of Immunology. 53(11). e2249923–e2249923. 14 indexed citations
3.
Hubert, Margaux, Élisa Gobbini, Coline Couillault, et al.. (2020). IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer. Science Immunology. 5(46). 105 indexed citations
4.
Hubert, Margaux, Coline Couillault, Thien‐Phong Vu Manh, et al.. (2020). Abstract A70: IFN-III is selectively produced by cDC1 and predicts good clinical outcome in human breast cancer. Cancer Immunology Research. 8(4_Supplement). A70–A70. 1 indexed citations
5.
Deauvieau, Florence, Anne‐Claire Doffin, Jean‐François Fonteneau, et al.. (2014). Human natural killer cells promote cross‐presentation of tumor cell‐derived antigens by dendritic cells. International Journal of Cancer. 136(5). 1085–1094. 54 indexed citations
6.
Hasan, Uzma, Christophe Caux, Ivan Perrot, et al.. (2007). Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proceedings of the National Academy of Sciences. 104(19). 8047–8052. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026